Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Prevalence of pre-diabetes and undiagnosed diabetes in the Mollerussa prospective observational cohort study in a semi-rural area of Catalonia.

Falguera M, Vilanova MB, Alcubierre N, Granado-Casas M, Marsal JR, Miró N, Cebrian C, Molló À, Franch-Nadal J, Mata-Cases M, Castelblanco E, Mauricio D.

BMJ Open. 2020 Jan 20;10(1):e033332. doi: 10.1136/bmjopen-2019-033332.

2.

How Many Patients with Type 2 Diabetes Meet the Inclusion Criteria of the Cardiovascular Outcome Trials with SGLT2 Inhibitors? Estimations from a Population Database in a Mediterranean Area.

Canivell S, Mata-Cases M, Vlacho B, Gratacòs M, Real J, Mauricio D, Franch-Nadal J.

J Diabetes Res. 2019 Nov 11;2019:2018374. doi: 10.1155/2019/2018374. eCollection 2019.

3.

Prevalence and coprevalence of chronic comorbid conditions in patients with type 2 diabetes in Catalonia: a population-based cross-sectional study.

Mata-Cases M, Franch-Nadal J, Real J, Cedenilla M, Mauricio D.

BMJ Open. 2019 Oct 28;9(10):e031281. doi: 10.1136/bmjopen-2019-031281.

4.

High levels of fasting glucose and glycosylated hemoglobin values are associated with hyperfiltration in a Spanish prediabetes cohort. The PREDAPS Study.

Rodríguez-Poncelas A, Franch-Nadal J, Coll-de Tuero G, Mata-Cases M, Alonso-Fernández M, Mur-Marti T, Ruiz A, Giraldez-García C, Regidor E.

PLoS One. 2019 Sep 19;14(9):e0222848. doi: 10.1371/journal.pone.0222848. eCollection 2019.

5.

Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: Prescription According to Reimbursement Constraints and Guideline Recommendations in Catalonia.

Franch-Nadal J, Mata-Cases M, Ortega E, Real J, Gratacòs M, Vlacho B, Vallés JA, Mauricio D.

J Clin Med. 2019 Sep 5;8(9). pii: E1389. doi: 10.3390/jcm8091389.

6.

Lactic acidosis associated with metformin in patients with moderate to severe chronic kidney disease: study protocol for a multicenter population-based case-control study using health databases.

Pedrós C, Ávila M, Gómez-Lumbreras A, Manríquez M, Morros R; ALIMAR-C2 Study Group.

BMC Nephrol. 2019 May 30;20(1):193. doi: 10.1186/s12882-019-1389-8.

7.

Glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes:real-world evidence from a Mediterranean area.

Mata-Cases M, Franch-Nadal J, Ortega E, Real J, Gratacòs M, Vlacho B, Mauricio D.

Curr Med Res Opin. 2019 Oct;35(10):1735-1744. doi: 10.1080/03007995.2019.1618806. Epub 2019 Jun 17.

PMID:
31081693
8.

Glycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non-insulin antidiabetic drugs in a real-world setting.

Canivell S, Mata-Cases M, Real J, Franch-Nadal J, Vlacho B, Khunti K, Gratacòs M, Mauricio D.

Diabetes Obes Metab. 2019 Jun;21(6):1373-1380. doi: 10.1111/dom.13663. Epub 2019 Mar 19.

PMID:
30756446
9.

Spanish Diabetes Society (SED) recommendations for the pharmacologic treatment of hyperglycemia in type 2 diabetes: 2018 Update.

Gomez-Peralta F, Escalada San Martín FJ, Menéndez Torre E, Mata Cases M, Ferrer García JC, Ezkurra Loiola P, Ávila Lachica L, Fornos Pérez JA, Artola Menéndez S, Álvarez-Guisasola F, Rica Echevarría I, Girbés Borrás J; en representación del Grupo de Trabajo de Consensos y Guías Clínicas.

Endocrinol Diabetes Nutr. 2018 Dec;65(10):611-624. doi: 10.1016/j.endinu.2018.08.004. Epub 2018 Oct 23. English, Spanish.

PMID:
30366843
10.

Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study.

Franch-Nadal J, Caballeria L, Mata-Cases M, Mauricio D, Giraldez-García C, Mancera J, Goday A, Mundet-Tudurí X, Regidor E; PREDAPS Study Group.

PLoS One. 2018 Jun 1;13(6):e0198327. doi: 10.1371/journal.pone.0198327. eCollection 2018.

11.

Decreased iron stores are associated with cardiovascular disease in patients with type 2 diabetes both cross-sectionally and longitudinally.

Suárez-Ortegón MF, McLachlan S, Price AH, Fernández-Balsells M, Franch-Nadal J, Mata-Cases M, Barrot-de la Puente J, Mundet-Tudurí X, Mauricio D, Ricart W, Wild SH, Strachan MWJ, Price JF, Fernández-Real JM.

Atherosclerosis. 2018 May;272:193-199. doi: 10.1016/j.atherosclerosis.2018.03.028. Epub 2018 Mar 21.

PMID:
29625295
12.

Consensus on insulin treatment in type 2 diabetes.

Girbés Borrás J, Escalada San Martín J, Mata Cases M, Gomez-Peralta F, Artola Menéndez S, Fernández García D, Ortega Millán C, Alvarez Guisasola F, Ferrer García JC, Ezkurra Loiola P, Escobar Jiménez F, Fornos Pérez JA, Galindo Rubio M, Rica Echevarría I, Menéndez Torre E.

Endocrinol Diabetes Nutr. 2018 Mar;65 Suppl 1:1-8. doi: 10.1016/j.endinu.2018.01.002. Epub 2018 Mar 2. English, Spanish. No abstract available.

PMID:
29503234
13.

[Managing the discharge of diabetic patients from the emergency department: a consensus paper].

Cuervo Pinto R, Álvarez-Rodríguez E, González Pérez de Villar N, Artola-Menéndez S, Girbés Borrás J, Mata-Cases M, Galindo Rubio M, Puig Larrosa J, Muñoz Albert R, Díaz Pérez JÁ.

Emergencias. 2017 Oct;29(5):343-351. Spanish.

14.

Epidemiology and clinical management of type 2 diabetes mellitus and associated comorbidities in Spain (e-Management study).

Franch Nadal J, Mata Cases M, Mauricio Puente D.

Med Clin (Barc). 2016 Nov;147 Suppl 1:1-7. doi: 10.1016/S0025-7753(17)30618-8. English, Spanish.

PMID:
28760219
15.

Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Factors predicting intensification of treatment.

Mata-Cases M, Franch-Nadal J, Real J, Gratacòs M, López-Simarro F, Khunti K, Mauricio D.

Diabetes Obes Metab. 2018 Jan;20(1):103-112. doi: 10.1111/dom.13045. Epub 2017 Jul 28.

PMID:
28656746
16.

Prevalence, clinical features and risk assessment of pre-diabetes in Spain: the prospective Mollerussa cohort study.

Vilanova MB, Falguera M, Marsal JR, Rubinat E, Alcubierre N, Castelblanco E, Granado-Casas M, Miró N, Molló À, Mata-Cases M, Franch-Nadal J, Mauricio D.

BMJ Open. 2017 Jun 11;7(6):e015158. doi: 10.1136/bmjopen-2016-015158. Erratum in: BMJ Open. 2017 Sep 18;7(9):e015158corr1.

17.

Impact of implementing electronic clinical practice guidelines for the diagnosis, control and treatment of cardiovascular risk factors: A pre-post controlled study.

Comin E, Catalan-Ramos A, Iglesias-Rodal M, Grau M, Del Val JL, Consola A, Amado E, Pons A, Mata-Cases M, Franzi A, Ciurana R, Frigola E, Cos X, Davins J, Verdu-Rotellar JM.

Aten Primaria. 2017 Aug - Sep;49(7):389-398. doi: 10.1016/j.aprim.2016.11.007. Epub 2017 Mar 15.

18.

Understanding the physical, social, and emotional experiences of people with uncontrolled Type 2 diabetes: a qualitative study.

Berenguera A, Molló-Inesta À, Mata-Cases M, Franch-Nadal J, Bolíbar B, Rubinat E, Mauricio D.

Patient Prefer Adherence. 2016 Nov 9;10:2323-2332. eCollection 2016.

19.

Attitudes towards insulin initiation in type 2 diabetes patients among healthcare providers: A survey research.

Escalada J, Orozco-Beltran D, Morillas C, Alvarez-Guisasola F, Gomez-Peralta F, Mata-Cases M, Palomares R, Iglesias R, Carratalá-Munuera C.

Diabetes Res Clin Pract. 2016 Dec;122:46-53. doi: 10.1016/j.diabres.2016.10.003. Epub 2016 Oct 14.

20.

Supplemental Content

Loading ...
Support Center